Avandia 8 mg Tablets
In September 2010, the U.S. Food and Drug Administration (FDA) announced that it was severely restricting the use of Avandia, due to the risk of "cardiovascular events" such as heart attacks and strokes. Only individuals who could not control their diabetes on other medications (or those who were already taking the medication and doing well) would be able to take Avandia.
However, in November 2013, the FDA announced that a careful analysis of the research suggests that there is not, in fact, any increased risk, compared to treatment with standard diabetes medications and that the use of this medication will no longer be restricted.
For type 2 diabetes treatment, the recommended starting dosage of Avandia® (rosiglitazone maleate) is 4 mg once daily (or 2 mg twice daily). If necessary, your healthcare provider may increase your dosage up to 8 mg of Avandia tablets once daily (or 4 mg twice daily) after 8 to 12 weeks. If you are taking insulin, the maximum recommended dosage of Avandia is 4 mg once daily (or 2 mg twice daily).
However, your specific dosage will depend on several factors, including:
- How well your diabetes is controlled
- Other medical conditions you may have
- Other medications you may be taking.
(Click Avandia Dosage for a more detailed look at when a healthcare provider may prescribe 8 mg tablets of Avandia. This article also describes the factors that can affect your dosage and offers tips on when and how to safely use this medication.)